Haptoglobin (Hp) binds free hemoglobin released from red cells and is an acute phase protein measured in hemolysis testing.
Athens Bioscience supplies human haptoglobin purified from plasma, lyophilized and salt-free at ≥95% purity by SDS-PAGE. This mixed-type preparation suits haptoglobin immunoassay development, hemoglobin binding studies, and antibody characterization where a single phenotype is not required. Phenotype 1-1, 2-1, and 2-2 preparations are also available.
Haptoglobin is a major acute-phase plasma glycoprotein present at concentrations of 100–300 mg/dL, primarily synthesized in the liver. Its central function is to bind free hemoglobin released during red blood cell breakdown, thereby preventing iron loss through the kidneys and reducing hemoglobin-driven oxidative tissue damage. This hemoglobin–haptoglobin complex is rapidly cleared by macrophages via the CD163 receptor, facilitating iron recycling and modulating antioxidant and anti-inflammatory pathways. Haptoglobin also influences immune responses, interacting with neutrophils, lymphocytes, and dendritic cells to regulate inflammation and adaptive immunity.
Humans exhibit three main haptoglobin phenotypes-Hp 1-1, Hp 2-1, and Hp 2-2-arising from genetic polymorphisms. Hp 1-1 demonstrates the highest hemoglobin-binding and antioxidant efficiency, while Hp 2-2 is least effective, which may explain its association with increased risk and severity of conditions such as cardiovascular disease, diabetes, and epilepsy. Notably, the Hp 2-2 phenotype is linked to poorer outcomes in coronary artery disease and more frequent epilepsy attacks, likely due to reduced antioxidant protection in neural tissues. Clinically, haptoglobin serves as a sensitive biomarker for hemolytic anemia, liver function, and as a potential prognostic marker in cancer and inflammatory diseases. Therapeutically, recombinant haptoglobin is being explored for treating hemolysis-related complications and as a neuroprotective agent following subarachnoid hemorrhage.
Common uses include metabolic studies, IVD Assay standards, calibrators and controls, therapeutics research, cardiovascular research, mass spectrometry, oxidative stress research.
Not a hazardous substance or mixture.
11 - Combustible Solids
Haptoglobin (Hp) binds free hemoglobin released from red cells and is an acute phase protein measured in hemolysis testing.
Athens Bioscience supplies human haptoglobin purified from plasma, lyophilized and salt-free at ≥95% purity by SDS-PAGE. This mixed-type preparation suits haptoglobin immunoassay development, hemoglobin binding studies, and antibody characterization where a single phenotype is not required. Phenotype 1-1, 2-1, and 2-2 preparations are also available.